HER2 Expressing Solid Tumours
1 clinical trials · Condition
◉ Watch HER2 Expressing Solid Tumours
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers (NCT02829372) | Ichnos Sciences SA | 2016-05-01 |
Track HER2 Expressing Solid Tumours automatically
Every clearance here is in the API, with alerts when new ones post.